Abbott Laboratories
Earnings Date & Report
Last updated:
Next earnings date: 14 Oct 2025
Abbott Laboratories’s last earnings date was on 16 Jul 2025.
Abbott Laboratories stock Earnings report, Estimates & History
| 2021-01-27 | 1.35 | 1.45 |
|---|---|---|
| 2021-04-20 | 1.33 | 1.32 |
| 2021-07-22 | 1.01 | 1.17 |
| 2021-10-20 | 0.95 | 1.4 |
| 2022-01-26 | 1.21 | 1.32 |
| 2022-04-20 | 1.47 | 1.73 |
| 2022-07-20 | 1.13 | 1.43 |
| 2022-10-19 | 0.91 | 1.15 |
| 2023-01-25 | 0.9 | 1.03 |
| 2023-04-19 | 0.98 | 1.03 |
| 2023-07-20 | 1.04 | 1.08 |
| 2023-10-18 | 1.1 | 1.14 |
| 2024-01-24 | 1.19 | 1.19 |
| 2024-04-17 | 0.955 | 0.98 |
| 2024-07-18 | 1.1 | 1.14 |
| 2024-10-16 | 1.2 | 1.21 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Abbott Laboratories stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 14 Oct 2025 | Not reported yet | N/A | ? | N/A | ? | |
| 16 Jul 2025 | N/A | N/A | N/A | N/A | N/A | |
| 15 Apr 2025 | N/A | N/A | N/A | N/A | N/A | |
| 22 Jan 2025 | N/A | $1.34 | N/A | 11.02B | N/A | |
| 16 Oct 2024 | Beat | $1.2 | $1.21 | 10.55B | 10.63B | |
| 18 Jul 2024 | Beat | $1.1 | $1.14 | 10.36B | 10.37B | |
| 17 Apr 2024 | Beat | $0.96 | $0.98 | 9.88B | 9.96B | Earnings Call Transcript |
| 24 Jan 2024 | Matched | $1.19 | $1.19 | 10.17B | 10.24B | Earnings Call Transcript |
| 18 Oct 2023 | Beat | $1.1 | $1.14 | 9.61B | 10.14B | Earnings Call Transcript |
| 20 Jul 2023 | Beat | $1.04 | $1.08 | 9.69B | 9.97B | Earnings Call Transcript |
| 19 Apr 2023 | Beat | $0.98 | $1.03 | 9.63B | 9.74B | |
| 25 Jan 2023 | Beat | $0.9 | $1.03 | 9.66B | 10.09B | Earnings Call Transcript |
| 19 Oct 2022 | Beat | $0.91 | $1.15 | 9.64B | 10.41B | Earnings Call Transcript |
| 20 Jul 2022 | Beat | $1.13 | $1.43 | 10.32B | 11.25B | Earnings Call Transcript |
| 20 Apr 2022 | Beat | $1.47 | $1.73 | 10.99B | 11.89B | Earnings Call Transcript |
| 26 Jan 2022 | Beat | $1.21 | $1.32 | 11.08B | 11.46B | Earnings Call Transcript |
| 20 Oct 2021 | Beat | $0.95 | $1.4 | 9.44B | 10.92B | Earnings Call Transcript |
| 22 Jul 2021 | Beat | $1.01 | $1.17 | 9.44B | 10.22B | Earnings Call Transcript |
| 20 Apr 2021 | Missed | $1.33 | $1.32 | 10.75B | 10.45B | |
| 27 Jan 2021 | Beat | $1.35 | $1.45 | 9.90B | 10.70B | Earnings Call Transcript |
Abbott Laboratories Earnings report FAQs
When is Abbott Laboratories's next Earnings date?
The next earnings date of Abbott Laboratories is on 14 Oct 2025.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.